• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

image

PLAY BUTTON

image

PLAY BUTTON

image

Progress

1/156

Click to flip

156 Cards in this Set

  • Front
  • Back
Which drugs should be given at even intervals apart (e.g. Q12 rather than BID)unless otherwise ordered?
Antibiotics, psychotropics, and cardiac drugs
CARDIAC GLYCOSIDE:

Digoxin (Lanoxin)
Indications:
CHF, A-fib or Supraventricular arrhythmias.
Digoxin (Lanoxin)
Three main actions
to increase myocardial contractility, decrease SA node activity and Decrease Cardiac conduction rates.
Digoxin (Lanoxin)
Important adverse effects:
Bradycardia, arrhythmias, yellow-green halos around visual images, nausea, anorexia, headache.
Digoxin (Lanoxin)
Notes:
-may require a loading dose to achieve a therapeutic effect.
-Monitor serum levels as window between therapeutic and toxic levels is narrow.
-Monitor Apical Pulse for one minute prior to administration. Hold for pulse< 60 or > 120 and notify MD.
-Hypomagnesemia, Hypokalemia and Hypercalcemia contribute to toxicity.
CALCIUM CHANNEL BLOCKERS:
Diltiazem (Cardizem)
Nicardipene (Cardene)
Nifedipine (Procardia)
Verapamil (Calan)
Amlodipine (Norvasc)
CALCIUM CHANNEL BLOCKERS:
Action
Decreased influx of calcium ions into calcium channels of myocardium and peripheral vasculature.
CALCIUM CHANNEL BLOCKERS:
Indication
HTN, Angina.
CALCIUM CHANNEL BLOCKERS:
Important A/E
Headache, fatigue, dizziness, edema, arrhythmias, hypotension, CHF. Bradycardia for Verapamil and Diltiazem.
BETA BLOCKERS:
Nadolol (Corgard)
Propranolol (Inderal)
Metoprolol (Lopressor)
Atenolol (Tenormin)
Metoprolol Succinate (Toprol XL)
Carvedilol (Coreg)
BETA BLOCKERS:
Actions
Blocks beta-adrenergic receptor stimulation
BETA BLOCKERS:
Indications
HTN, Tachycardia,CHF, angina.
BETA BLOCKERS:
Important A/E
Bradycardia, CHF, Hypotension, worsened peripheral vascular disease, bronchospasms, depression, heart block, fatigue.
BETA BLOCKERS:
Note:
-can mask symptoms of hypoglycemia.
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
Enalapril (Vasotec)
Lisinopril (Prinivil or Zestril)
Ramopril (Altace)
Quinapril (Accupril)
(ACE) INHIBITORS
Actions
Inhibit conversion of Angiotensin I to Angiotensin II. Results in decreased vasoconstriction and decreased aldosterone secretion.
(ACE) INHIBITORS
Indications
HTN, CHF.
(ACE) INHIBITORS
Important A/E
Impaired renal function, neutropenia, Headache, Hypotension, Cough, Angioedema, Hyperkalemia,
Lightheadedness.
(ACE) INHIBITORS
Note:
-Severe first dose hypotension can occur warn patient.
Angiotensin Receptor Blockers (ARBs)
Valsartan (Diovan)
Losartan (Cozaar)
Candesartan (Atacand)
Angiotensin Receptor Blockers (ARBs)
Action
Block angiotensin II receptors resulting in decreased vasoconstriction and decreased aldosterone secretion.
Angiotensin Receptor Blockers (ARBs)
Indications & A/E
same as ACE inhibitors except lower incidence of cough and angioedema.
SALICYLATES:

Aspirin
Action
decreases platelet aggregation. Centrally acting antipyretic, analgesic and antinflammatory.
SALICYLATES:

Aspirin
Indications
Pain, fever, inflammation, prophylaxis of cardiovascular disease.
SALICYLATES:

Aspirin
Important A/E
Prolonged bleeding time, Tinnitus, Abnormal Liver Functions, Worsened Asthma, Ulcers, GI Bleed.
NON-STEROIDAL ANTIIMFLAMMATORY DRUGS (NSAIDS):
Diclofenac Sodium (Voltaren) Ketorolac Tromethamine (Toradol)
Flurbiprofen (Ansaid) Sulindac (Clinoril)
Ibuprofen (Motrin) Naproxen Sodium (Naprosyn)
Indomethacin (Indocin) Piroxican (Feldene)
Nabumetone (Relafen)
(NSAIDS):
Action
Decrease pain and inflammation through inhibition of prostaglandin.
(NSAIDS):
Indications
Musculoskeletal Pain, Arthritis, Headache, Mild to Moderate Pain.
(NSAIDS):
Important A/E
Abdominal Pain, GI Bleed, Renal Toxicity, Elevated liver Enzymes, Worsened Bronchospasms, Fluid Retention, Hypertension.
COX-2 Inhibitor
Celecoxib (Celebrex) Possible association with MI

(Similar to NSAIDS but less incidence of GI Bleed or Ulcers)
BENZODIAZIPINES
Indicated for Insomnia:
Flurazepam (Dalmane)
Temazepam (Restoril)
Zolpidem (Ambien)
Alprazolam (Xanax)
Diazepam (Valium)
Lorazepam (Ativan)
Chlordiazepoxide (Librium)
Clonazepam (Klonopin)
Zolpidem (Ambien)
has shorter half-life less AM “hangover” less tendency for tolerance or rebound insomnia.
BENZODIAZIPINES
Action
Enhances GABA a CNS depressant neurotransmitter.
BENZODIAZIPINES
Indications
Anxiety, Muscle relaxants, Anticonvulsants, Alcohol Withdrawal.
BENZODIAZIPINES
Important A/E
Drowsiness, Lethargy, Ataxia, Hypotension, Dry Mouth, Addiction.
BENZODIAZIPINES
Notes:
-Do not withdraw abruptly.
-The elderly are vulnerable to accumulation and toxicity.
Antidepressants

Selective serotonin re-uptake inhibitors (SSRIs)
Fluoxetine (Prozac)
Paroxetine (Paxil)
Setraline(Zoloft)
Citalopram (Celexa)
Escitalopram (Lexapro)
(SSRIs)
Action
Decreases re-uptake of Serotonin a neurotransmitter.
(SSRIs)
Indication
Depression, Anxiety
(SSRIs)
A/E
Tremors, anxiety, insomnia, nausea, anorexia, diarrhea, constipation, increased appetite, weight loss, seizures
(SSRIs)
Notes:
Cannot be given within 14 days of administration of an MAO inhibitor: can trigger Hypertensive crisis. Assess for suicide risk
Combined SSRI/Neurepinephrine re-uptake inhibitors
Duloxetine (Cymbalta)
Venlafaxine (Effexor)
Combined SSRI/Neurepinephrine re-uptake inhibitors
Actions
Inhibits re-uptake of Serotonin and Neurepinephrine
Combined SSRI/Neurepinephrine re-uptake inhibitors
Indications
Depression and Anxiety
Combined SSRI/Neurepinephrine re-uptake inhibitors
A/E
Same as SSRIs plus increased BP
ANTICONVULSANTS

CARBAMAZIPINE (TEGRETOL):
Indications
Anticonvulsant, Affective disorders.
ANTICONVULSANTS

CARBAMAZIPINE (TEGRETOL):
Important A/E
Aplastic Anemia, Agranulocytosis, Thrombocytopenia, Dizziness, Sedation, GI Distress.
ANTICONVULSANTS

CARBAMAZIPINE (TEGRETOL):
Notes
-Monitor serum blood levels.
-Monitor CBC.
ANTICONVULSANTS

PHENYTOIN (DILANTIN):
Indications
Anticonvulsant, Antiarrthymic.
ANTICONVULSANTS

PHENYTOIN (DILANTIN):
Action
Slows sodium channels.
ANTICONVULSANTS

PHENYTOIN (DILANTIN):
Important A/E
Pancytopenia, Megoblastic Anemia, Ataxia, Slurred Speech, Confusion, Arrthymias, Hypotension, Gingival Hyperplasia, Lupus Erthymatosous.
ANTICONVULSANTS

PHENYTOIN (DILANTIN):
Notes:
-Monitor serum blood levels, CBC, B12, and Folic acid Levels.
ANTICONVULSANTS

Gabapentin (Neurontin):
Indications
Anticonvulsant, Neuropathic pain, Agitation
ANTICONVULSANTS

Gabapentin (Neurontin):
Important A/E
Fatigue, somnolence, dizziness, ataxia, peripheral edema, nausea, vomiting, constipation, decreased WBC count.
ANTICONVULSANTS

Gabapentin (Neurontin):
Notes:
-withdrawal slowly if discontinued,
-can cause false positive for urine protein.
ANTICONVULSANTS

Levetiracetam (Keppra)
Indications
Anticonvulsant
ANTICONVULSANTS

Levetiracetam (Keppra)
Important A/E
Fatigue, Somnolence, Ataxia, Dizziness, Bone Marrow Depression, Psychosis, Suicidal Behavior
NEUROLEPTICS
Haloperidol (Haldol)
Thioridazine (Mellaril)
Thiothixene (Navane)

Atypicals:
Olanzapine (Zyprexa)
Risperidone (Risperdal)
Quetiapine (Seroquel)
NEUROLEPTICS
Indications
Psychosis, Agitation.
NEUROLEPTICS
Important A/E
Extrapyramidal symptoms (Parkinson like rigidity and tremors)., Tardive Dyskinesia, Neuroleptic Malignant Syndrome (High Fever, Tachycardia, Tachypnea, Diaphoresis, rare but often fatal)., Sedation, Confusion, Constipation, Urinary Retention, Dry Mouth, orthostatic hypotension.
NEUROLEPTICS
Notes
-Haldol and Navane have a high rate of EPS but a lower rate of sedation.
-Mellaril has a low incidence of EPS but a high rate of sedation.
-Atypicals cause less EPS but tend to cause weight gain.
BRONCHODILATORS
METAPROTERAL (ALUPENT)(short acting)
ALBUTEROL (PROVENTIL) (short acting)
Salmeterol (Serevent) (long acting)
Levalbuterol (Xopenex) (Short Acting)
BRONCHODILATORS
Indication
Asthma, Bronchospasm.
BRONCHODILATORS
Action
Work by increasing action of sympathetic nervous system at Beta receptors.
BRONCHODILATORS
Important A/E
Tremors, Agitation, Tachycardia, HTN, Palpitations.
BRONCHODILATORS
Notes:
-Can be given by MDI(Metered Dose Inhaler) or Nebulization,
-Effective for routine or PRN use.
-Teach proper use of inhaler.
IPRATROPIUM BROMIDE (ATROVENT)
Indication
Maintenance treatment of bronchospasms associated with COPD.
IPRATROPIUM BROMIDE (ATROVENT)
Action
Works by inhibition of the Parasympathetic Nervous System.
IPRATROPIUM BROMIDE (ATROVENT)
Important A/E
Nervousness, Dizziness, palpitations, tachycardia, cough
IPRATROPIUM BROMIDE (ATROVENT)
Notes
-Not appropriate for emergency use.
-Teach proper use of MDI.
THEOPHYLLINE (THEO-DUR)
Indications
Prophylaxis and symptomatic relief of bronchospasm of Asthma or COPD.
THEOPHYLLINE (THEO-DUR)
Important A/E
Restlessness, Dizziness, Seizures, Headache, Tachycardia, Palpitations, Hypotension, Nausea and Vomiting.
THEOPHYLLINE (THEO-DUR)
Notes:
-Monitor serum blood levels.
INHALED STEROID:
BECLOMETHASONE (BECLOVENT, VANCERIL)
Triamcinolone (AZMACORT)
Fluticasone (Flovent)
INHALED STEROID:
Actions
Decrease airway inflammatory response with topical steroid.
INHALED STEROID:
Indications
Bronchospastic disease not responsive to Bronchodilators.
INHALED STEROID:
Important A/E
Hoarseness, Fungal Infections of Mouth and Throat.
INHALED STEROID:
Notes
-Not for Acute use.
-Instruct patient to rinse mouth after use to prevent candidiasis.
-Administer after Bronchodilators if being given concurrently.
Combination Inhalers:
Advair: combines Flovent with Serevent
Combivent: combines albuterol with Atrovent
ORAL STEROID:
PREDNISONE
Methylprednisolone (Medrol)
Dexamethasone (Decadron)
ORAL STEROID:
Action
Potent antiinflammatory has glucocorticoid and mineralcorticoid effects.
ORAL STEROID:
Indications
Severe Inflammation, Allergic Reactions, Bronchospasms.
ORAL STEROID:
Important A/E
Psychosis, Edema, Fluid Retention, Hyperglycemia, Immunosupression, Hypokalemia, GI Bleed, Poor Wound Healing, GI Distress.
ORAL STEROID:
Notes
-Abrupt Withdrawal causes rebound inflammation and can be fatal.
-Administer with food or milk.
DIURETICS:

THIAZIDES
Hydrochlorithiazide (HCTZ) etc.
DIURETICS:

THIAZIDES
Action
Inhibits sodium reabsorption in the distal renal tubule.
DIURETICS:

THIAZIDES
Indications
HTN, Edema
DIURETICS:

THIAZIDES
Important A/E
Hypotension, hypokalemia, hyponatremia hyperglycemia, volume depletion, gout.
LOOP DIURETICS
Bumetandine (Bumex)
Furosemide (Lasix)
LOOP DIURETICS
Indications
Renal Failure, CHF, HTN.
LOOP DIURETICS
Action
More potent than thiazide. Inhibits sodium reabsorption in renal tubule at loop of henle.
LOOP DIURETICS
Important A/E
Blood Dyscrasias, Volume Depletion, Orthostatic Hypotension, Hypokalemia, hyponatremia Hyperglycemia.
POTASSIUM SPARING DIURETICS
Spironolacane (Aldactone)
Triamterene (Dyenium)
POTASSIUM SPARING DIURETICS
Indications
Edema, HTN, CHF.
POTASSIUM SPARING DIURETICS
Action
Inhibits distal convoluted tubule aldosterone receptors
POTASSIUM SPARING DIURETICS
Important A/E
Hyperkalemia, Headache, Anorexia, Dehydration, Elevated BUN, Acidosis, Hypotension.
DIURETICS
COMBINATION PRODUCTS:
DYAZIDE (Triamterene 50mg and HCTZ 25mg)

MAXZIDE (Triamterene 75mg and HCTZ 50mg)

Given to minimize potassium imbalances caused by other diuretics.
H2 BLOCKERS:
Cimetidine (Tagamet)
Famotidine (Pepcid)
Nizatidine (Axid)
Ranitidine (Zantac)
H2 BLOCKERS:
Indications
Douodenal Ulcers, Esophagitis and esophageal reflux.
H2 BLOCKERS:
Action
Blocks H2 receptors
H2 BLOCKERS:
Important A/E
Blood Dyscrasias, diarrhea, nausea, constipation.
H2 BLOCKERS:
Notes:
Tagamet has more interactions with other drugs than the other H2 blockers.
Proton Pump Inhibitors (PPIs):
Omeprazole (Prilosec)
Lansoprazole (Prevacid)
Pantoprazole (protonix)
Esomeprazole (Nexium)
Rabeprazole (Aciphex)
Proton Pump Inhibitors (PPIs):
Indications
Esophagitis, Gastroesophogeal reflux disease, Duodenal Ulcer
Proton Pump Inhibitors (PPIs):
Action
Inhibits gastric parietal cell proton pump
Proton Pump Inhibitors (PPIs):
Important A/E
headache, dizziness, cough, nausea, vomiting, constipation, flatulence
Proton Pump Inhibitors (PPIs):
Notes:
-Can increase serum levels of diazepam, phenytoin and coumadin monitor closely.
ORAL HYPOGLYCEMICS:
Chlorpromide (Diabinese)
Glipizide (Glucotrol)
Glyburide (Diabeta, Micronase)
Glimepiride (Amaryl)
ORAL HYPOGLYCEMICS:
Indications
Glucose Control in Type II Diabetes Mellitus.
ORAL HYPOGLYCEMICS:
Action
Stimulate beta cell activity in the pancreas
ORAL HYPOGLYCEMICS:
Important A/E
Hypoglycemia, dizziness, jaundice.
ORAL HYPOGLYCEMICS:
Notes:
-Monitor Blood Glucose if indicated.
-Look for symptoms of hypoglycemia.
-Educate patient about his disease, diet and management of hypoglycemic episodes.
TZDs
Rosiglitazone(Avandia)
Pioglitazone (Actos)
TZDs
Indications
Adjunct to diet and insulin control of Type II diabetes.
TZDs
Action
Insulin sensitizer.
TZDs
Important A/E
Headache, peripheral edema, elevated liver enzymes, nausea, diarrhea, hypoglycemia when used in conjunction with insulin.
TZDs
Notes:
-monitor liver enzymes,
-monitor blood glucose for response/ hypoglycemia. Contraindicated in CHF
Metformin (Glucophage)
Indication
Adjunctive control of blood glucose in Type 2 diabetes.
Metformin (Glucophage)
Action
Decreased hepatic glucose production and insulin sensitizer.
Metformin (Glucophage)
A/E
diarrhea, nausea, vomiting, bloating, lactic acidosis, megablastic anemia
Metformin (Glucophage)
Notes:
Contraindicated for patients with impaired renal function (increased risk of lactic acidosis) Hold when patient dehydrated or receives contrast dyes.
THYROID SUPPLEMENTS:
Levothyroxine (Synthroid) (Levoxyl)
Thyroid Dessicated (Armour Thyroid)
THYROID SUPPLEMENTS:
Indication
Hypothyroidism
THYROID SUPPLEMENTS:
Action
Thyroid hormone replacement
THYROID SUPPLEMENTS:
Important A/E
Toxicity as evidenced by nervousness, insomnia, tachycardia, arrhythmias, angina, HTN, heat intolerance.
THYROID SUPPLEMENTS:
Notes:
-Monitor TSH and other thyroid values.
WARFARIN SODIUM (COUMADIN):
Indications
Prevention of thrombus formation.
WARFARIN SODIUM (COUMADIN):
Action
Inhibits production of Vitamin K dependent clotting factors.
WARFARIN SODIUM (COUMADIN):
Important A/E
Hemorrhage, GI Bleed, Bruises, Anemia secondary to bleeding.
WARFARIN SODIUM (COUMADIN):
Notes:
-Monitor Protime/INR closely.
-Vitamin K is an antidote to Coumadin.
-Avoid Concurrent administration of ASA or NSAIDS.
- Educate patient about risks and precautions associated with drug.
Clopidogrel (Plavix):
Indications
Cardiovascular prophylaxis by decreased platelet aggregation
Clopidogrel (Plavix):
A/E
hemorrhage, edema, and ulcer
Clopidogrel (Plavix):
Notes
Use caution with NSAIDS, ASA or coumadin due to increased risk of bleeding or ulcer
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin)
Enoxaparin (Lovenox) (low molecular weight heparin)

Indications
Prevention or treatment of DVT or thromboembolism
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin)
Enoxaparin (Lovenox) (low molecular weight heparin)

Action
Inhibits thrombin and conversion of fibrinogen to fibrin
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin)
Enoxaparin (Lovenox) (low molecular weight heparin)

A/E
Bleeding/hemorrhage
Heparin (Unfractionated)
Fondaparinux (Arixtra) (low molecular weight heparin)
Enoxaparin (Lovenox) (low molecular weight heparin)

Notes
Monitor platelet count and PTT for heparin. Lab monitoring not required for low molecular weight heparins after initiation. Do not aspirate or rub subcutaneous injection.
CARBIDOPA/LEVODOPA (SINEMET):
Indications
Parkinson's
CARBIDOPA/LEVODOPA (SINEMET):
Actions
Increases CNS availability of Dopamine
CARBIDOPA/LEVODOPA (SINEMET):
Important A/E
Nervousness, Hemolytic Anemia, Delirium, Hallucinations, Ataxia, Orthostatic Hypotension, Nausea and Vomiting, anorexia, Urinary Retention.
Entacapone (Comtan)
Indication
Adjunctive to Sinemet for Parkinsons
Entacapone (Comtan)
Action
Decreases peripheral metabolism of Sinemet increases amount available to CNS.
Entacapone (Comtan)
Important A/E
Dyskinesias, Hypotension, Diarrhea, Hallucinations, and Syncope
Stalevo:
Combination of Sinemet and Comtan
Acetocholinesterase Inhibitors
Donzepezil (Aricept)
Rivastigmine (Exelon)
Galantamine (Reminyl)
Acetocholinesterase Inhibitors
Indication
Mild to moderate dementia of the Alzheimer's Type.
Acetocholinesterase Inhibitors
Action
Inactivates acetocholinesterase an enzyme that breaks down acetylcholine.
Acetocholinesterase Inhibitors
Important A/E
Headache, insomnia, dizziness, depression, vertigo, ataxia, aphasia, syncope, HTN, hypotension, atrial fib, cataracts, blurred vision, nausea, diarrhea, vomiting, fecal incontinence, weight loss.
Memantine (Namenda)
Indication
Alzheimer’s
Memantine (Namenda)
Action
Decreases NMDA an excitatory neurotransmitter
Memantine (Namenda)
Important A/E
Somnolence, Hallucinations, Fatigue, Nausea, Vomiting, and Constipation
Narcotics
Morphine
Hydromorphone (Dilaudid)
Meperidine (Demerol)
Codeine
Oxycodone
Oxycodone with Acetominophen (Percocet)
Hydrocodone with Acetominphen (Vicodin)
Long acting Oxycodone (Oxycontin)
Fentanyl (Duragesic)
Narcotics
Indications
Moderate to severe pain
Narcotics
Actions
Binds to opiate receptors
Narcotics
Important A/E
Respiratory Depression, Sedation, Nausea/Vomiting, and Constipation
Narcotics
Notes
Give oral forms with food. Titrate to pain levels. Monitor bowel function. Administer Laxative as ordered for patient using more than 1-2 days. Long-term use will result in withdrawal symptoms if stopped abruptly.